	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	217	260	322	390	411	454	519	610	687	785	922	1,112	1,372	1,666	1,875
Cost of Operating Revenue	38	103	126	168	175	225	255	309	326	384	487	566	668	790	712
Gross Profit	179	157	196	222	236	229	264	301	360	401	435	545	704	876	1,163
Gross Margin	82.4	60.3	60.9	56.9	57.5	50.4	50.9	49.3	52.5	51.1	47.2	49.1	51.3	52.6	62.0
Total Operating Expenses	97	205	258	324	346	386	428	518	563	618	763	904	1,078	1,296	1,548
Operating Profit	121	55	65	65	65	68	91	92	123	167	159	208	294	370	327
Operating Margin	55.5	21.1	20.0	16.8	15.7	15.0	17.5	15.1	18.0	21.2	17.3	18.7	21.5	22.2	17.4
Financing Income/(Expense) - Net	-16	-22	-12	-3	-1	3	2	0	-3	3	8	11	16	28	-18
Profit before Taxes	29	33	63	85	65	75	97	100	126	180	195	237	344	453	427
Income Taxes	10	10	19	23	18	20	26	35	30	44	49	58	86	114	107
Profit after Tax	19	24	45	62	48	55	71	65	96	136	147	179	258	339	322
PAT Margin	9.0	9.3	14.0	16.0	11.7	12.1	13.6	10.7	14.0	17.3	15.9	16.1	18.8	20.3	17.2
EPS - Basic - ex Extraordinary Items	2.21	2.75	5.12	7.07	5.47	6.25	8.00	7.41	10.86	15.25	15.28	18.69	26.92	34.13	31.79
EPS - Diluted - ex Extraordinary Items	2.21	2.75	5.11	7.07	5.47	6.25	8.00	7.41	10.86	15.24	15.27	18.67	26.90	34.11	31.75
EBIT	121	55	65	65	65	68	91	92	123	167	159	208	294	370	327
EBITDA	132	68	79	84	86	92	120	129	164	214	213	265	358	453	442
EBITDA Margin	61.0	26.1	24.4	21.6	20.9	20.2	23.2	21.2	23.9	27.3	23.1	23.9	26.1	27.2	23.6

Balance Sheet

Abridged

Understanding Balance Sheet

Poly Medicure Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	C 2013 Mar 31	R 2014 Mar 31	C 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	81	94	120	160	171	205	255	302	318	706	783	807	842	1,917	1,942
Long-Term Investments	-	-	-	-	1	1	6	6	6	5	4	1	21	7	19
Property Plant & Equipment - Net	85	93	133	165	178	206	258	270	332	391	477	662	889	1,130	1,354
Total Non-Current Assets	101	120	166	205	216	252	310	352	450	518	593	770	1,017	1,275	1,977
Total Assets	182	214	286	364	387	457	565	654	767	1,224	1,377	1,577	1,859	3,192	3,919
Total Current Liabilities	61	68	89	113	106	114	123	154	197	171	227	293	351	370	576
Long Term Debt	18	24	39	40	31	48	79	91	114	65	39	19	3	1	57
Total Non-Current Liabilities	27	34	51	55	50	71	102	117	133	82	59	40	34	54	192
Total Liabilities	88	102	140	168	156	185	224	271	330	254	286	333	386	424	768
Total Shareholders' Equity	94	112	146	196	231	272	340	383	437	970	1,091	1,244	1,473	2,769	3,108
Minority Interest	0	0	0	0	0	0	0	-	-	-	-	-	-	-	43
Total Equity	94	112	146	196	231	272	340	383	437	970	1,091	1,244	1,473	2,769	3,151
Total Liabilities & Equity	182	214	286	364	387	457	565	654	767	1,224	1,377	1,577	1,859	3,192	3,919

Cash Flow

Abridged

Understanding Cash Flow Statement

Poly Medicure Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	R 2014 Mar 31	2015 Mar 31	C 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	34	39	61	77	71	75	105	106	138	175	187	235	309	399	397
Working Capital - Increase/(Decrease)	-8	-6	-2	-21	-14	-24	-37	-9	-12	-61	-63	-50	-41	-154	-149
Net CF from Operating Activities	26	33	59	56	57	51	68	97	126	114	124	185	269	244	248
Capital Expenditures - Net	27	31	58	51	33	56	82	76	106	95	154	239	275	330	306
Net CF from Investing Activities	-27	-31	-59	-60	-33	-58	-91	-104	-115	-439	-90	-181	-255	-1,209	-243
Dividends Paid - Cash - Total	3	3	5	10	27	13	5	21	42	-	24	24	29	30	35
Stock - Issuance/(Retirement) - Net	-	-	0	0	-	-	-	0	0	400	0	0	0	1,000	0
Debt - LT & ST - Issuance/(Retirement) - Total	4	2	18	13	4	20	31	28	32	-68	-7	20	19	6	71
Net Cash Flow from Financing Activities	0	-2	13	2	-23	7	26	7	-10	325	-31	-4	-9	962	36
Free Cash Flow to Equity	4	4	19	18	28	15	16	50	52	-49	-38	-35	13	-79	14
Free Operating CF net dividend	-4	-1	-5	-9	-2	-20	-20	-2	-23	18	-56	-79	-37	-117	-96
Free Operating CF	-1	2	0	2	24	-7	-15	19	20	18	-32	-55	-8	-87	-60

Business Segment Analysis

FY End:

Mar 25

Poly Medicure Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

MEDICAL DEVICES (100.0%)₹ 331.03 Cr

Revenue / Sales

MEDICAL DEVICES (100.0%)₹ 1,665.98 Cr

Assets

MEDICAL DEVICES (100.0%)₹ 3,192.45 Cr

Operating Income

MEDICAL DEVICES (100.0%)₹ 370.20 Cr

Regional Segment Analysis

FY End:

Mar 25

Poly Medicure Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

Outside India (70.7%)₹ 1,170.89 CrWith in India (29.3%)₹ 484.13 Cr

Historical Segment Analysis

Track how Poly Medicure Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

MEDICAL DEVICES	106	95	156	239	277	331

Frequently Asked Questions

What is the revenue of Poly Medicure Ltd.?

The latest trailing twelve month revenue of Poly Medicure Ltd. is ₹ 1,875.26 Cr, reflecting a 1-year growth of 12.56% and a 3-year CAGR of 19.03%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Poly Medicure Ltd.?

The latest trailing twelve month net profit (PAT) of Poly Medicure Ltd. is ₹ 322.14 Cr, with a 3-year earnings CAGR of 19.36%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Poly Medicure Ltd.?

The trailing twelve month EBITDA of Poly Medicure Ltd. is approximately ₹ 326.80 Cr (based on an operating margin of 17.43%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Poly Medicure Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Poly Medicure Ltd. is 31.75. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Poly Medicure Ltd.?

The debt-to-equity ratio of Poly Medicure Ltd. stands at 0.11. The interest coverage ratio is 17.87x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Poly Medicure Ltd.?

The estimated book value per share of Poly Medicure Ltd. is 306.61 (derived from a P/B ratio of 5.48 and market price of ₹ 1,680.50), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Poly Medicure Ltd.?

The trailing twelve month operating cash flow of Poly Medicure Ltd. is ₹ 248.22 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Poly Medicure Ltd. report consolidated or standalone financials?

Poly Medicure Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.